2,5-dimethoxy-4-bromoamphetamine has been researched along with 4-iodo-2,5-dimethoxy-beta-phenethylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frescas, S; Gudelsky, GA; Huang, X; Marona-Lewicka, D; Nash, JF; Nichols, DE; Roth, BL | 1 |
| Clare, BW | 1 |
2 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and 4-iodo-2,5-dimethoxy-beta-phenethylamine
| Article | Year |
|---|---|
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
Topics: 3T3 Cells; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; Cell Line; Discrimination, Psychological; Frontal Lobe; Hippocampus; Iodine Radioisotopes; Ketanserin; Male; Mice; Phenethylamines; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Tritium | 1994 |
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens.
Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory | 1998 |